Functional mechanisms and potential therapeutic strategies for lactylation in liver diseases
Graphical Abstract Sample Work
Lactylation is a new lactate-mediated protein post-translational modification (PTM) that has recently been found to be a master regulator of gene expression and protein function by modifying histone and non-histone proteins.
A metabolic map drawn inside the liver
This graphical abstract accompanies a review by Xu and colleagues, published in Life Sciences in 2025, on the functional mechanisms of lactylation in liver diseases and the therapeutic strategies that could target it. Instead of dividing the canvas into panels, the designer places the entire pathway inside a translucent liver silhouette. Glucose enters on the left, lactate is produced and transported, protein lactylation forms at the centre, and three disease outcomes branch off at the lower right. Drug names appear in grey boxes at the points they act.
The figure is aimed at hepatologists, metabolism researchers and drug discovery teams exploring post-translational modifications as targets.
Lactate as a signal, not only a waste product
Lactylation is a post-translational modification in which a lactyl group derived from lactate is added to lysine residues on histone and non-histone proteins. First described on histones in 2019, it links cellular metabolism directly to gene regulation and protein function: when glycolysis increases and lactate accumulates, lactylation can change which genes are expressed and how proteins behave. Like acetylation, it is added by "writer" enzymes and removed by "eraser" enzymes.
The liver handles large lactate fluxes and is central to glucose metabolism, so it is a natural place to study this modification. The review connects lactylation to liver injury, fibrosis and liver cancer, conditions in which altered glycolysis is frequently reported.
Tracing the pathway from glucose to lactylated protein
Following the black arrows, the figure sets out the metabolic route:
- Glucose enters through GLUT transporters and is phosphorylated by hexokinase (HK) to glucose-6-phosphate (G6P).
- Glycolysis converts G6P to pyruvate.
- Pyruvate is either converted to lactate by LDHA or directed by pyruvate dehydrogenase (PDH) to acetyl-CoA and the TCA cycle. LDHB, shown downstream of PGC-1α, catalyses the reverse conversion of lactate to pyruvate.
- Lactate is moved across membranes by monocarboxylate transporters (MCT).
- Lactate feeds P300, drawn as the writer that produces protein lactylation, while HDAC1 and SIRT1/3, each tagged "LA", represent enzymes that act on lactylation marks.
Blue arrows then lead from the lactylated protein to liver injury, liver fibrosis and liver cancer, each shown as a small liver illustration with distinctive surface changes.
Where the candidate drugs act
The therapeutic dimension of the review is represented by grey boxes with red arrows or blunt-ended inhibition lines:
- 2-DG acting on hexokinase, and HSPA12A shown restraining glycolysis.
- Oxamate on LDHA, limiting lactate production.
- DCA (dichloroacetate) on PDK, which otherwise inhibits PDH; this diverts pyruvate towards the TCA cycle.
- CHC on MCT, limiting lactate transport.
- C646 on P300, the lactylation writer.
- Apicidin directed at HDAC1, and SRT2183 and HKL directed at SIRT1/3.
Using one visual vocabulary (red blunt lines for inhibition, red arrows for modulation) across all targets lets readers see at a glance that the review discusses intervention at nearly every step, from glucose uptake to the modification itself.
Strengths and limits of a single-scene design
Placing every element inside one organ outline gives the figure coherence and avoids the fragmentation of multi-panel layouts. The cost is density: around twenty labels share the canvas. The figure manages this by using a pale liver background, consistent box styles for drugs and enzyme shapes for proteins, and by placing the citation and a three-sentence summary outside the liver. The summary states that lactylation has advanced understanding of hepatic pathologies and that the review suggests avenues for future clinical intervention; it does not claim that any listed compound is an established therapy, which is appropriate for a review of mainly preclinical evidence.
Two further details help. The three disease outcomes are drawn as livers with progressively altered surfaces, so injury, fibrosis and cancer read as related stages rather than unrelated endpoints. And lactate itself appears twice, as red dots near LDHA and again beside the MCT transporter, which shows visually that the same metabolite is both produced inside hepatocytes and exchanged with the surrounding environment.
Adapting this approach for a mechanistic review
Review authors covering a metabolic pathway can borrow the organ-as-canvas idea, provided the pathway is linear enough to follow. Decide first which steps the review actually discusses, then add interventions only at those steps. Pubrica's graphical abstract service develops figures of this type, and manuscript editing can help align the review's text with the terminology used in the figure.
Questions about this sample
What is lactylation and why does the figure place it at the centre?
Lactylation is the addition of lactate-derived lactyl groups to lysine residues on proteins, including histones. It links metabolic activity to gene regulation. The figure places protein lactylation at the centre because it is the point where the upstream metabolic pathway converges and from which arrows lead to liver injury, fibrosis and cancer.
Which enzymes write or remove lactylation in the figure?
P300 is shown as the enzyme that uses lactate to produce protein lactylation, and C646 is drawn inhibiting it. HDAC1 and SIRT1/3 are marked with lactyl tags, representing enzymes that act on lactylation marks, with apicidin, SRT2183 and honokiol (HKL) shown as compounds targeting them.
Are the drugs in the grey boxes approved treatments for liver disease?
The figure presents them as candidate tools or strategies discussed in the review for modifying lactate production, transport or lactylation. Most of the evidence for this approach in liver disease is preclinical, and the figure's summary refers to potential future interventions rather than established therapies.
Give yourself the academic edge today
Each order includes
- On-time delivery or your money back
- A fully qualified writer in your subject
- In-depth proofreading by our Quality Control Team
- 100% confidentiality, the work is never re-sold or published
- Standard 7-day amendment period
- A paper written to the standard ordered
- A detailed plagiarism report
- A comprehensive quality report
Enquire Now
